Skip to main content
Premium Trial:

Request an Annual Quote

Hitachi, OriGene Ink Assay Development, Marketing Pact

NEW YORK (GenomeWeb News) – Hitachi Software Engineering America and OriGene Technologies said after the close of the market on Friday that they have entered into a co-marketing agreement to jointly promote products for assay development.

Specifically, the firms will co-market OriGene's multiplex assays built on Luminex xMAP/Bio-Plex technology with Hitachi's MasterPlex software suite for analysis and reporting of multiplex assay data. As part of the deal, OriGene will use the MasterPlex software exclusively in all immunoassay and custom assay development, the firms said. Customers who purchase OriGene's assays will be offered the use of the MasterPlex software for 30 days, they added.

Among OriGene's products are multiplexed assays for microRNA expression, transcription factors profiling, and genotyping.

"Going forward, OriGene and Hitachi Software plan to leverage our new partnership to bring an even broader range of research and analysis solutions to our current and future life sciences customers," Robert Lynde, director of sales for Hitachi Software, said in a statement.

Financial and further terms of the alliance were not disclosed.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.